Thus, in view of high s1pr2 expression in cholangiocytes and its correlation with cholangiocarcinoma and cholestatic liver disease, we chose s1pr2 as a promising candidate receptor to study its role during HCC progression in our zebrafish model. This evidence concerns the gene S1PR2 and Cholestatic liver disease.